Mostrando ítems 1-10 de 13
AIDS Clinical Research in SpainLarge HIV Population, Geniality of Doctors, and Missing Opportunities
The first cases of AIDS in Spain were reported in 1982. Since then over 85,000 persons with AIDS have been cumulated, with 60,000 deaths. Current estimates for people living with HIV are of 145,000, of whom 20% are unaware ...
COVID-19 Comes 40 Years After AIDS - Any Lesson?
(AIDS Reviews, 2020-06)
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. In 1981, the first cases of AIDS were reported and wide diagnostic ...
Very long-acting antivirals as chemovaccines for preventing viral infections
(AIDS Reviews, 2020-04)
Following the advent of penicillin as first widely used antibiotic during World War II, viruses have steadily replaced bacteria as major agents of infections, particularly for microorganisms that can spread globally. Good ...
Impact of New Coronavirus Epidemics on HIV-Infected Patients
(AIDS Reviews, 2020)
Since the first report of a cluster of pneumonia cases in Wuhan (China) at the end of 2019 due to a new airborne highly transmissible coronavirus known as SARS-CoV-2, large-scale spreading has rapidly become a global ...
Hospital admissions in individuals with HTLV-1 infection in Spain
OBJECTIVE: To examine the clinical burden and disease spectrum, as well as time trends for human T-cell leukemia virus type 1 (HTLV-1) and HTLV type 2 (HTLV-2) hospital admissions. DESIGN: Retrospective, observational study ...
Long-acting antiretroviral therapy
(Nature Materials, 2020-08-01)
Nanoformulations of cabotegravir prodrugs have been developed to prolong the pharmacokinetics of the antiretroviral agent. They can be present in the plasma of mice and non-human primates for a year following a single injection.
Advances in hepatitis B therapeutics
(Therapeutic Advances in Infectious Disease, 2020-10)
Despite the availability of both effective preventive vaccines and oral antivirals, over 250 million people are chronically infected with the hepatitis B virus (HBV). Globally, chronic hepatitis B is the leading cause of ...
Why such excess of mortality for COVID-19 in Spain?
(Therapeutic Advances in Infectious Disease, 2020-06)
The current global crisis produced by the SARS-CoV-2 pandemic is unprecedented. Even the 1918 influenza pandemic (Spanish flu) did not halt the planet so abruptly and deeply as it ran during World War I.
Hot news: Unveiling long COVID-19 disease
(AIDS Reviews, 2020)
The clinical spectrum of “Severe Acute Respiratory Syndrome Coronavirus type 2” (SARS-CoV-2) infection is wider than initially thought. The coronavirus does not establish a chronic cellular infection, in contrast with HIV ...
Rapid antigen Testing and Mask Wearing While Waiting for COVID-19 Vaccines
(AIDS reviews, 2020)
After the rapid surge of COVID-19 in Europe during the spring of 2020, implementation of lockdowns succeeded in drastically reduce the number of cases and deaths within 2-3 months. However, it came at a heavy socioeconomic ...